{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:06:50Z","timestamp":1793106410638,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30503","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:17:47Z","timestamp":1714490267000},"page":"e30503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: In vitro study"],"prefix":"10.1016","volume":"10","author":[{"given":"Soraya","family":"Shahbazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5021","authenticated-orcid":false,"given":"Farzaneh","family":"Tafvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Naseh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e30503_bib1","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.2147\/IJN.S426849","article-title":"The therapeutic effects of MUC1-C shRNA@ Fe3O4 magnetic nanoparticles in alternating magnetic Fields on Triple-negative breast cancer","author":"Li","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2024.e30503_bib2","first-page":"401","article-title":"Functionalized liposomes for targeted breast cancer drug delivery","volume":"24","author":"Nel","year":"2023","journal-title":"Bioact. Mater."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e30503_bib3","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.31557\/APJCP.2019.20.7.2015","article-title":"Global trend of breast cancer mortality rate: a 25-year study","volume":"20","author":"Azamjah","year":"2019","journal-title":"Asian Pac. J. Cancer Prev. APJCP: Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.heliyon.2024.e30503_bib4","first-page":"1077","article-title":"Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective","author":"He","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30503_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10837450.2019.1703739","article-title":"Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment","volume":"25","author":"Yassemi","year":"2020","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10837450.2018.1455698","article-title":"Preparation and characterization of letrozole-loaded poly (d, l-lactide) nanoparticles for drug delivery in breast cancer therapy","volume":"24","author":"Alemrayat","year":"2019","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e30503_bib7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1039\/D2ME00024E","article-title":"Evaluation of anti-cancer and anti-metastatic effects of folate-PEGylated niosomes for co-delivery of letrozole and ascorbic acid on breast cancer cells","volume":"7","author":"Bourbour","year":"2022","journal-title":"Molecular Systems Design & Engineering"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30503_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12645-019-0055-y","article-title":"Nanomedicine review: clinical developments in liposomal applications","volume":"10","author":"Beltr\u00e1n-Gracia","year":"2019","journal-title":"Cancer Nanotechnology"},{"key":"10.1016\/j.heliyon.2024.e30503_bib10","first-page":"319","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.heliyon.2024.e30503_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"J. Pharmaceut. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e30503_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-7799(98)01220-7","article-title":"Novel applications of liposomes","volume":"16","author":"Lasic","year":"1998","journal-title":"Trends Biotechnol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","article-title":"Lipophilic drug derivatives in liposomes","volume":"165","author":"Gulati","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30503_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Research in pharmaceutical sciences"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30503_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/ijms19010195","article-title":"Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review","volume":"19","author":"Riaz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30503_bib16","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2024.e30503_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30503_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10717544.2015.1092183","article-title":"Lipid-based nanocarriers for breast cancer treatment\u2013comprehensive review","volume":"23","author":"Talluri","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e30503_bib19","first-page":"337","article-title":"PEGylation in anti-cancer therapy: an overview","volume":"11","author":"Mishra","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ijms21020559","article-title":"Enhanced efficacy of PEGylated liposomal cisplatin: in vitro and in vivo evaluation","volume":"21","author":"Ghaferi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30503_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e30503_bib22","article-title":"Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities","author":"Parsa","year":"2023","journal-title":"Helion"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30503_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0271-5317(00)00149-4","article-title":"Dietary fibre from edible seaweeds: chemical structure, physicochemical properties and effects on cholesterol metabolism","volume":"20","author":"Jim\u00e9nez-Escrig","year":"2000","journal-title":"Nutr. Res. (N.Y.)"},{"key":"10.1016\/j.heliyon.2024.e30503_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jcou.2017.02.001","article-title":"Supercritical CO2 assisted liposomes formation: Optimization of the lipidic layer for an efficient hydrophilic drug loading","volume":"18","author":"Trucillo","year":"2017","journal-title":"J. CO2 Util."},{"key":"10.1016\/j.heliyon.2024.e30503_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.colsurfa.2016.07.040","article-title":"Charge boosting effect of cholesterol on cationic liposomes","volume":"506","author":"Aramaki","year":"2016","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.heliyon.2024.e30503_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.705886","article-title":"Liposomes: structure, biomedical applications, and stability parameters with emphasis on cholesterol","volume":"9","author":"Nakhaei","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e30503_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BSR20090104","article-title":"Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics","volume":"30","author":"Deniz","year":"2010","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.heliyon.2024.e30503_bib28","first-page":"49","article-title":"Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy","author":"Chang","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e30503_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/1735-5362.213979","article-title":"Factors affecting liposomes particle size prepared by ethanol injection method","volume":"12","author":"Shaker","year":"2017","journal-title":"Research in pharmaceutical sciences"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30503_bib30","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.nano.2017.04.009","article-title":"Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting","volume":"13","author":"Tang","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.heliyon.2024.e30503_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30503_bib32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3390\/pharmaceutics14061153","article-title":"In vitro Nephrotoxicity and permeation of Vancomycin Hydrochloride loaded liposomes","volume":"14","author":"Papp","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2024.e30503_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.matlet.2020.127839","article-title":"Urea-silica nanohybrids with potential applications for slow and precise release of nitrogen","volume":"272","author":"de Silva","year":"2020","journal-title":"Mater. Lett."},{"key":"10.1016\/j.heliyon.2024.e30503_bib34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-981-15-6426-0_11","article-title":"Role of kinetic models in drug stability","author":"Rehman","year":"2020","journal-title":"Drug Stability and Chemical Kinetics"},{"key":"10.1016\/j.heliyon.2024.e30503_bib35","doi-asserted-by":"crossref","first-page":"121077","DOI":"10.1016\/j.biomaterials.2021.121077","article-title":"Glycogen-based pH and redox sensitive nanoparticles with ginsenoside Rh2 for effective treatment of ulcerative colitis","volume":"280","author":"Xu","year":"2022","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e30503_bib36","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/pharmaceutics11110610","article-title":"Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment","volume":"11","author":"Najlah","year":"2019","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e30503_bib37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.3390\/pharmaceutics14102183","article-title":"Impact of PEGylated liposomal doxorubicin and carboplatin combination on glioblastoma","volume":"14","author":"Ghaferi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30503_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acsami.9b16150","article-title":"PEGylation of paclitaxel-loaded cationic liposomes drives steric stabilization of bicelles and vesicles thereby enhancing delivery and cytotoxicity to human cancer cells","volume":"12","author":"Steffes","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.heliyon.2024.e30503_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1066887","article-title":"PEGylation and folic-acid functionalization of cationic lipoplexes\u2014improved nucleic acid transfer into cancer cells","volume":"10","author":"Hoffmann","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08982104.2016.1191021","article-title":"PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU","volume":"27","author":"He","year":"2017","journal-title":"J. Liposome Res."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e30503_bib41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1080\/03639045.2018.1451880","article-title":"Delivery of vinblastine-containing niosomes results in potent in vitro\/in vivo cytotoxicity on tumor cells","volume":"44","author":"Amiri","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30503_bib42","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3390\/pharmaceutics14061125","article-title":"The pH-responsive liposomes\u2014the effect of PEGylation on release kinetics and cellular uptake in glioblastoma cells","volume":"14","author":"Rustad","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30503_bib43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules23020268","article-title":"Anticancer efficacy of targeted shikonin liposomes modified with RGD in breast cancer cells","volume":"23","author":"Wen","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e30503_bib44","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3892\/or.2012.1868","article-title":"Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of Cyclin A and Cyclin D1 in colorectal cancer cells","volume":"28","author":"Yang","year":"2012","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e30503_bib45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/25.7.894009","article-title":"Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources","volume":"25","author":"Young","year":"1977","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.heliyon.2024.e30503_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2015.10.037","article-title":"Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro","volume":"220","author":"Sriraman","year":"2015","journal-title":"J. Contr. Release"},{"issue":"21","key":"10.1016\/j.heliyon.2024.e30503_bib47","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1073\/pnas.1000401107","article-title":"KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation","volume":"107","author":"Hsia","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2024.e30503_bib48","first-page":"2733","article-title":"CyclinD1 protein expressed in pterygia is associated with \u03b2-catenin protein localization","volume":"16","author":"Tung","year":"2010","journal-title":"Mol. Vis."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e30503_bib49","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.1074\/jbc.272.16.10882","article-title":"Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2","volume":"272","author":"Prall","year":"1997","journal-title":"J. Biol. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024065344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024065344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:06:22Z","timestamp":1775732782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024065344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024065344"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30503","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the efficacy of letrozole-loaded PEGylated nanoliposomes against breast cancer cells: In vitro study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30503"}}